You H. Mo

Department Of Shandong Provincial Key Laboratory Of Precision Oncology
Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A supramolecular peptide reprograms PD-L1+ tumor-associated macrophages to enhance antitumor immunity in lung adenocarcinoma.

A supramolecular peptide reprograms PD-L1+ tumor-associated macrophages to enhance antitumor immunity in lung adenocarcinoma.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 09, 2025

Treatment-Related Cardiotoxicity in Non-Small Cell Lung Cancer: A Population-Based Analysis for Risk Stratification.

Treatment-Related Cardiotoxicity in Non-Small Cell Lung Cancer: A Population-Based Analysis for Risk Stratification.

Journal: QJM : monthly journal of the Association of Physicians

Published: October 27, 2025

Circulating Tumor DNA is Associated With Pathologic Response and Survival Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy: A Systematic Review and Meta-Analysis.

Circulating Tumor DNA is Associated With Pathologic Response and Survival Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy: A Systematic Review and Meta-Analysis.

Journal: Archivos de bronconeumologia

Published: September 15, 2025

Induction chemotherapy administration increases the risk of radiation pneumonitis in unresectable stage III NSCLC patients undergoing concurrent chemoradiotherapy with immunotherapy.

Induction chemotherapy administration increases the risk of radiation pneumonitis in unresectable stage III NSCLC patients undergoing concurrent chemoradiotherapy with immunotherapy.

Journal: Therapeutic advances in medical oncology

Published: September 03, 2025

Pharmacovigilance Signal for ILD Reporting with Magnesium Oxide and Immunoradiotherapy in NSCLC: An Observational Study.

Pharmacovigilance Signal for ILD Reporting with Magnesium Oxide and Immunoradiotherapy in NSCLC: An Observational Study.

Journal: Archivos de bronconeumologia

Published: May 09, 2025

Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy.

Early Immune Checkpoint Inhibitor Administration Increases the Risk of Radiation-Induced Pneumonitis in Patients with Stage III Unresectable NSCLC Undergoing Chemoradiotherapy.

Journal: Cancers

Published: March 30, 2025

Temporal trends in treatment-related cardiopulmonary disease-specific mortality in NSCLC based on pathological subtypes: a retrospective population-based cohort study.

Temporal trends in treatment-related cardiopulmonary disease-specific mortality in NSCLC based on pathological subtypes: a retrospective population-based cohort study.

Journal: Therapeutic advances in medical oncology

Published: March 29, 2025

The burden of COVID-19 death for different cancer types: a large population-based study.

The burden of COVID-19 death for different cancer types: a large population-based study.

Journal: Journal of global health

Published: February 13, 2025

Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC.

Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 11, 2025

Variants in KLF4 affecting residue Asp441 cause an autosomal dominant syndromic ichthyosis.

Variants in KLF4 affecting residue Asp441 cause an autosomal dominant syndromic ichthyosis.

Journal: The British journal of dermatology

Published: December 01, 2024

Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue.

Risk of second primary cancer in young breast cancer survivors: an important yet overlooked issue.

Journal: Therapeutic advances in medical oncology

Published: November 26, 2024

Gut Escherichia coli promotes lung cancer by increasing circulating STAMBP production.

Gut Escherichia coli promotes lung cancer by increasing circulating STAMBP production.

Journal: Discover oncology

Published: November 25, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026